To assess the risk of immunologic rejection episodes if topical corticosteroids are discontinued 1 year after Descemet's membrane endothelial keratoplasty (DMEK) compared with continued once-per-day use.
Powered by Börsen-Handelssysteme
Powered by Börsen-Handelssysteme